Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.40B | $70.19 | -2.19% | $102.16M | 55.71x | 0.26 | United States | ||
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $4.43B | $27.92 | 0.69% | $97.52M | 68.10x | 1.54 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $885.79M | $13.06 | -0.31% | $17.67M | 50.23x | 0.30 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $725.24M | $7.53 | -4.08% | $9.86M | 188.25x | 0.25 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $2.46B | $33.15 | -1.69% | $19.04M | 552.50x | 0.34 | Bermuda | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.17B | $143.96 | -1.60% | $175.01M | 28.17x | 0.09 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.19B | $69.98 | 1.48% | $791.84M | 15.62x | 5.17 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.10B | $37.52 | -0.64% | $831.10M | 17.45x | 0.32 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $20.99B | $36.00 | 0.22% | $1.29B | 15.58x | 0.93 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.58B | $12.03 | -1.55% | $86.50M | 27.34x | 0.50 | Canada | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.29B | $20.52 | -1.25% | $125.47M | 33.64x | 0.87 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.83B | $36.17 | -0.41% | $22.06M | 258.36x | 0.42 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $40.09B | $656.89 | -0.67% | $811.30M | 26.25x | 0.18 | Belgium | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.09B | $36.40 | -0.03% | $265.05M | 11.52x | 0.43 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $16.69B | $85.46 | 0.64% | $1.36B | 19.33x | 0.40 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.16B | $17.44 | -1.08% | $163.11M | 19.82x | 0.40 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.22B | $3.96 | 3.94% | $79.10M | 36.00x | -8.48 | United States | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | NASDAQ | Biotechnology | $80.62M | $11.48 | 0.00% | $24.86M | 15.73x | -2.05 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.06B | $7.19 | 0.00% | $54.38M | 32.68x | 0.34 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $8.60B | $54.87 | 2.96% | $289.57M | 66.11x | 0.31 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.32B | $29.57 | -1.66% | $63.03M | 68.77x | 0.10 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $244.59B | $54.78 | 1.92% | $24.46B | 14.06x | 1.87 | Denmark | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.00B | $57.31 | -0.23% | $934.37M | 16.66x | 0.24 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $768.02M | $9.63 | -4.84% | $19.78M | 41.87x | 0.43 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.48B | $20.25 | 0.10% | $310.08M | 11.71x | 0.14 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $15.28B | $23.82 | 1.71% | $1.82B | 12.09x | 0.22 | Denmark | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $100.19B | $390.76 | 0.23% | $4.59B | 27.67x | 0.40 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.